Add BrightSurf on Google Email

Experimental blood test predicts risk for developing COPD, other severe respiratory diseases

A new preclinical blood test identifies adults most likely to develop severe respiratory conditions, including chronic obstructive pulmonary disease (COPD), by analyzing 32 proteins that accurately predict lung health data. The risk score indicates a high likelihood of hospital care, COPD development, and respiratory disease death.

SourceNIH/National Heart, Lung and Blood Institute·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateSep 10, 2024

People with COPD, asthma have higher risk of health problems from increased wildfire activity, smoke

A new perspective article highlights the impact of wildfires on individuals with COPD and asthma. The five-part Population Health Approach, developed by the University of California, Davis Health, identifies high-risk patients and provides interventions to mitigate poor air quality's negative effects.

SourceCOPD Foundation·JournalChronic Obstructive Pulmonary Diseases Journal of the COPD Foundation·DateAug 14, 2024

CHEST Critical Care and CHEST Pulmonary receive indexation with Directory of Open Access Journals

The American College of Chest Physicians' CHEST Critical Care and CHEST Pulmonary journals have been indexed with the Directory of Open Access Journals (DOAJ), enhancing their open access content's accessibility and usage. The indexation is attributed to strong editorial boards led by Hayley Gershengorn and Matthew Miles.

SourceAmerican College of Chest Physicians·JournalCHEST Critical Care·DateMay 23, 2024

Brigham study finds eliminating race-based metrics improves prediction for COPD outcomes

A new study found that using race-neutral equations for lung function test interpretation accurately predicted risk of death and COPD flare-ups, especially for African Americans. The study suggests reclassifications can allow those most in need to gain eligibility for specialized treatments like lung transplant.

SourceBrigham and Women's Hospital·JournalAmerican Journal of Respiratory and Critical Care Medicine·TypeObservational study·DateMay 21, 2024

Second Phase 3 clinical trial again shows dupilumab lessens disease in COPD patients with type 2 inflammation

Researchers report that dupilumab substantially decreases exacerbation frequency and improves lung function as well as symptom burden in COPD patients with type 2 inflammation. The study's findings are promising for these patients, who have a high risk of exacerbations.

SourceUniversity of Alabama at Birmingham·JournalNew England Journal of Medicine·TypeExperimental study·DateMay 20, 2024

World-first trial shows benefits of finding, treating undiagnosed asthma and COPD

A world-first clinical trial found that finding and treating people with undiagnosed asthma or COPD improves their health and reduces healthcare visits. The study, which involved 508 patients, showed that those treated by a lung specialist and educator averaged fewer healthcare visits and improved symptoms compared to usual care.

SourceThe Ottawa Hospital·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMay 19, 2024

Spirometry clinical trial eligibility may differ with race-neutral equations

Research found that race-neutral spirometry equations tend to decrease severity for white patients and increase severity for Black patients, leading to higher enrollment rates of Black patients in COPD clinical trials. This shift resulted in more Black subjects meeting typical inclusion criteria, while fewer white subjects were eligible.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMay 19, 2024

New imaging software improves lung diagnosis for 30% of patients who can't tolerate contrast dye; has added diagnostic benefits for all patients

Researchers developed CT-Derived Functional Imaging, a software program that calculates lung volume changes and blood mass without contrast dye. The technology has improved diagnoses for up to 30% of patients who couldn't tolerate contrast dye, and also benefits all patients with lung issues such as COPD and cancer.

The Lundquist Institute receives $2.6 million grant from U.S. Army Medical Research Acquisition Activity to develop wearable biosensors

The Lundquist Institute has been awarded a four-year, $2.6 million grant to develop wearable multiplex biosensors that can monitor exacerbation risk in COPD. The proposed sensors have the potential to revolutionize COPD management and transform chronic disease management by providing real-time, non-invasive monitoring.

Wildfire smoke disproportionately affects California's Indigenous communities, new research shows

Researchers found that Indigenous communities in California were exposed to 1.7 times more wildfire smoke than expected, with the average annual exposure being a critical factor in understanding long-term health effects. The study proposes new metrics to measure cumulative exposure and duration of smoke exposure.

SourceUniversity of California - Berkeley·JournalProceedings of the National Academy of Sciences·TypeData/statistical analysis·DateFeb 29, 2024

Office air conditioning can reduce the risk of harm from wildfire smoke

A new study by the University of Technology Sydney suggests that office air conditioning can reduce the risk of harm from wildfire smoke. The researchers found that air conditioning filters in UTS Buildings 4 and 7 captured a significant portion of wildfire smoke, reducing exposure to toxic particles for staff and students.

SourceUniversity of Technology Sydney·JournalEnvironmental Pollution·TypeObservational study·DateJan 21, 2024

Palliative telecare significantly improves quality of life for those with chronic illnesses, and results last for months

Researchers found that a team intervention provided by phone leads to persistent improvements in depression, anxiety, and quality of life for people managing chronic illnesses. The program demonstrated early, persistent, and clinically meaningful improvements in adults with COPD, HF, or ILD.

SourceUniversity of Colorado Anschutz Medical Campus·JournalJournal of the American Medical Association·DateJan 16, 2024

Trazadone and CBT no more effective than placebo for improving insomnia among long-term dialysis patients

A clinical trial found that trazodone and cognitive behavioral therapy for insomnia were no more effective than placebo in improving insomnia symptoms among long-term dialysis patients. Serious adverse events also occurred more frequently with trazodone use. More trials are needed to investigate additional therapies for this condition.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateJan 15, 2024

Unlocking the secrets of disease-causing fungus Aspergillus fumigatus

A ground-breaking study published in Nature Communications sheds light on the intricate mechanisms underlying the virulence of Aspergillus fumigatus, specifically focusing on the crucial role of mycotoxin gliotoxin production. The research team identified pivotal roles played by GliT oxidoreductase and GtmA methyltransferase in the sel...

SourceMaynooth University·JournalNature Communications·TypeExperimental study·DateJan 4, 2024

Beetroot juice supplement lowers blood pressure and improves exercise capacity in people with chronic obstructive pulmonary disease

A 12-week beetroot juice supplement reduced systolic blood pressure by 4.5mmHg and increased walking distance by 30 meters in COPD patients. The nitrate-rich supplement improved cardiovascular risk markers, suggesting potential benefits for everyday life and heart disease prevention.

SourceEuropean Respiratory Society·JournalEuropean Respiratory Journal·TypeRandomized controlled/clinical trial·DateDec 19, 2023

One in 3 adults with new-onset AFib occurring during hospitalization will have recurrent episode within a year

A study of hospitalized adults with new-onset atrial fibrillation found that 1 in 3 patients experienced a recurrent episode of AF within a year. This rate is approximately 7 times higher than in matched control participants, suggesting that oral anticoagulation therapy may be warranted for these patients.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateOct 2, 2023

Hospital admissions for COPD increased substantially, especially in women and younger people

Annual COPD hospital admissions in Canada increased substantially between 2002 and 2017, with a notable rise in females and younger adults. The number of hospital admissions for COPD has rapidly increased since 2010, suggesting that progress may not be being made in improving COPD care and outcomes.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeData/statistical analysis·DateSep 11, 2023

Large study suggests people with low levels of vitamin K have less healthy lungs

A large study published in ERJ Open Research found that people with low levels of vitamin K in their blood are more likely to have poor lung function and experience respiratory issues. The research suggests that vitamin K may play a role in keeping lungs healthy, but further studies are needed to confirm this link.

SourceEuropean Respiratory Society·JournalERJ Open Research·TypeObservational study·DateAug 9, 2023

Millions of long-term smokers have lung disease that defies diagnosis

A new study by UCSF found that half of participants with extensive tobacco exposure had persistently high respiratory symptoms, yet performed well in COPD tests. The study highlights a gap in effective care for tobacco-exposed individuals and emphasizes the need for broader definition of smoking-related lung disease.

SourceUniversity of California San Francisco Medical Center·JournalJournal of the American Medical Association·TypeObservational study·DateAug 1, 2023

Specific DNA modifications are linked to certain conditions including breast cancer, type II diabetes and COPD in an epigenetic study of over 18,000 people in Scotland

An epigenetic study of over 18,000 people in Scotland identified associations between certain DNA modifications and increased risks of breast cancer, type II diabetes, and chronic obstructive pulmonary disease (COPD). The findings provide new insights into the underlying mechanisms of these diseases.

SourcePLOS·JournalPLOS Medicine·DateJul 6, 2023

AJRCCM “Abstracts Issue” showcases research at the ATS 2023 International Conference

The American Thoracic Society International Conference Abstracts publication features selected abstracts on COPD treatment, including a study on improving depression through home-based pulmonary rehabilitation. The issue also highlights recent findings on sleep apnea severity, as well as research on health equity and access to care.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMay 1, 2023